MARKETS 1h ago
Lab rats: Activating ‘natural killers’ for cancer with Zumutor
Livemint Companies
Published 16 Oct 2026, 10:57 am IST
Zumutor Biologics is betting on a novel cancer drug that activates natural killer cells. With its lead candidate in phase 1 trials, the startup faces the challenge of turning early clinical signals into a licensing deal and investor returns.
Curated summary — originally published by Livemint Companies.Source: livemint.com
Related reads
Economic Times Markets · 5h
US Market: Fed's Goolsbee says latest US inflation data is discouraging
Livemint Markets · 5h
Nilesh Shah of Kotak says easing tax burden may help attract foreign flows, but won't be enough
Livemint Markets · 5h
Reliance Jio IPO: Should investors chase listing gains or focus on long-term value? Experts weigh in
Economic Times Markets · 5h
AI debt crisis? CoreWeave sell-off rattles tech investors